How can we facilitate research on the risks and potential benefits of novel psychoactive substances?
Ramaekers JG, Bade R, Hall W · 2026
Read How can we facilitate research on the risks and potential benefits of novel psychoactive substances? by Ramaekers JG, Bade R, Hall W (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311992.txt.
Description
Ramaekers JG, Bade R, and Hall W argue in a 2026 article for research-friendly rules on novel psychoactive substances. These synthetic drugs copy banned drugs while dodging treaties, and little is known of their harms or possible medical uses.
Strict scheduling, the authors say, blocks the very studies needed to judge a substance. They propose four stages: early surveillance for new substances and harms, provisional scheduling that allows regulated research, controlled studies of effects and abuse risk, and reclassification on the full evidence. The frame aims at drug policy that protects health without freezing science out.
Catalog record
| CREATOR | Ramaekers JG, Bade R, Hall W |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20369 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |